Niosome-Encapsulated Gentamicin for Ophthalmic Controlled Delivery

A. Cabanes, F. Reig, and J.M. Garcia-Anton. Evaluation of free and liposome-encapsulated gentamicin for intramuscular sustained release in rabbits. Res. Vet. Sci. 64:213–217 (1998).

N.C. Megoulas, and M.A. Koupparis. Development and validation of a novel LC/ELSD method for the quantitation of gentamicin sulphate components in pharmaceuticals. J. Pharm. Biomed. Anal. 36:73–79 (2004).

I.P. Kaur, A. Garg, A.K. Singla, and D. Aggarwal. Vesicular systems in ocular delivery: an overview. Int. J. Pharm. 269:1–14 (2004).

J. Frucht-Pery, H. Mechoulam, C.S. Siganos, P. Ever-Hadani, M. Shapiro, and A. Domb. Iontophoresis–gentamicin delivery into the rabbit cornea, using a hydrogel delivery probe. Exp. Eye Res. 78:745–749 (2004).

M.J. Blanco-Prıeto, C. Lecaroz, M.J. Renedo, J. Kunkova, and C. Gamazo. In vitro evaluation of gentamicin released from microparticles. Int. J. Pharm. 242:203–206 (2002).

R.E. Records. Gentamicin in ophthalmology. Surv. Ophthalmol. 21:49–58 (1976).

V. Baeyens, V. Kaltsatos, B. Boisramé, E. Varesio, J.L. Veuthey, M. Fathi, L.P. Balant, M. Gex-Fabry, and R. Gurny. Optimized release of dexamethasone and gentamicin from a soluble ocular insert for the treatment of external ophthalmic infections. J. Control Release. 52:215–220 (1998).

V. Baeyens, O. Felt-Baeyens, S. Rougier, S. Pheulpin, B. Boisramé, and R. Gurny. Clinical evaluation of bioadhesive ophthalmic drug inserts (BODI®) for the treatment of external ocular infections in dogs. J. Control Release. 85:163–168 (2002).

D.G. Colo, and Y. Zambito. A study of release mechanisms of different ophthalmic drugs from erodible ocular inserts based on poly (ethylene oxide). Eur. J. Pharm. Biopharm. 54:193–199 (2002).

I.F. Uchegbu, and S.P. Vyas. Non ionic surfactant based vesicles (niosomes) in drug delivery. Int. J. Pharm. 172:33–70 (1998).

M. Carafa, E. Santucci, F. Alhaique, T. Coviello, E. Murtas, F.M. Riccieri, G. Lucania, and M.R. Torrisi. Preparation and properties of new unilamellar non-ionic surfactant vesicles. Int. J. Pharm. 160:51–59 (1998).

M. Carafa, E. Santucci, and G. Lucania. Lidocaine-loaded non ionic surfactant vesicles: characterization and in vitro permeation studies. Int. J. Pharm. 231:21–32 (2002).

M.F. Saettone, G. Perini, M. Carafa, E. Santucci, and F. Alhaique. Non-ionic surfactant vesicles as ophthalmic carriers for cyclopentolate. A preliminary evaluation. S. T. P. Pharma. Sci. 6:94–98 (1996).

S.P. Vyas, N. Mysore, V. Jaittley, and N. Venkatesan. Discoidal niosome based controlled ocular delivery of timolol maleate. Pharmazie. 53:466–469 (1998).

K. Green, and S. Downs. Ocular penetration of pilocarpine in rabbits. Arch. Ophthalmol. 93:1165–1168 (1975).

N. Keller, D. Moore, D. Carper, and A. Longiwell. Increased corneal permeability by the dual effect of the transient tear film acidification and exposure to benzalkonium chloride. Exp. Eye Res. 30:203–210 (1980).

N.L. Burstein. Preservative alteration of corneal permeability in human and rabbits. Invest. Ophthalmol. Vis. Sci. 25:1453 (1984).

I.P. Kaur, and R. Smitha. Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery. Drug Dev. Ind. Pharm. 28:353–369 (2002).

A.J. Baillie, A.T. Florence, L.R. Hume, G.T. Muirhead, and A. Rogerson. The preparation and properties of niosomes non-ionic surfactant vesicles. J. Pharm. Pharmacol. 37:863–868 (1985).

R. Agarwal, O.P. Katare, and S.P. Vyas. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int. J. Pharm. 228:43–52 (2001).

X. Zhang, U.P. Wyss, D. Pichora, and M.F.A. Goosen. Biodegradable controlled antibiotic release devices for osteomyelitis: optimization of release properties. J. Pharm. Pharmacol. 46:718–24 (1994).

K. Ruckmani, B. Jayakar, and S.K. Ghosal. Nonionic surfactant vesicles (niosomes) of cytarabine hydrochloride for effective treatment of leukemia: encapsulation, storage and in vitro release. Drug Dev. Ind. Pharm. 26:217–222 (2000).

M. Benchimol, B. Piva, L. Campanati, and W. De Souza. Visualization of the funis of Giardia lamblia by high-resolution field emission scanning electron microscopy-new insights. J. Struc. Bio. 147:102–115 (2004).

P. Arunothayanun, M.S. Bernard, D.Q.M. Craig, I.F. Uchegbu, and A.T. Florence. The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether. Int. J. Pharm. 201:7–14 (2000).

O.N. El-Gazayerly, and A.H. Hikal. Preparation and evaluation of acetazolamide liposomes as an ocular delivery system. Int. J. Pharm. 158:121–127 (1997).

G.N. Devaraj, S.R. Parakh, R. Devraj, S.S. Apte, B.R. Rao, and D. Rambhau. Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol. J. Colloid Interface Sci. 251:360–365 (2002).

M. Glavas-Dodov, K. Goracinova, K. Mladenovska, and E. Fredro-Kumbaradzi. Release profile of lidocaine HCl from topical liposomal gel formulation. Int. J. Pharm. 242:381–384 (2002).

N.J. Van Haeringen. Clinical biochemistry of tears. Surv. Ophthalmol. 5:84–96 (1981).

J. Ceulemans, A. Vermeire, E. Adriaens, J.P. Remon, and A. Ludwig. Evaluation of a mucoadhesive tablet for ocular use. J. Control Release. 77:33–344 (2001).

A. Gursoy, E. Kut, and S. Ozkirmli. Co-encapsulation of isoniazid and rifampicin in liposomes and characterization of liposomes by derivative spectroscopy. Int J Pharm. 271:115–123 (2004).

S. Tamilvanana, and S. Benitab. The potential of lipid emulsion for ocular delivery of lipophilic drugs. Eur. J. Pharm. Biopharm. 58:357–368 (2004).

D.G. Colo, S. Burgalassi, P. Chetoni, M.P. Fiaschi, Y. Zambito, and M.F. Saettone. Gel-forming erodible inserts for ocular controlled delivery of ofloxacin. Int. J. Pharm. 215:101–111 (2001).

Y. Hao, F. Zhao, N. Li, Y. Yang, and K. Li. Studies on a high encapsulation of colchicine by a niosome system. Int. J. Pharm. 224:73–80 (2002).

R.A. RajaNaresh, G.K. Pillai, N. Udupa, and G. Chandrashekar. Anti-inflammatory activity of niosome encapsulated diclofenac sodium in arthritic rats. Indian. J. Pharmacol. 26:46–48 (1994).

C. Cable. An examination of the effects of surface modifications on the physicochemical and biological properties of non-ionic surfactant vesicles. PhD Thesis. University of Strathclyde, Glasgow, UK (1989).

A. Rogerson, J. Cummings, and A.T. Florence. Adriamycin- loaded niosomes-drug entrapment, stability and release. J. Microencap. 4:321–328 (1987).

E. Gianasi, F. Cociancich, I.F. Uchegbu, A.T. Florence, and R. Duncan. Pharmaceutical and biological characterization of a doxorubicin polymer conjugate (PK1) entrapped in sorbitan monostearate Span 60 niosomes. Int. J. Pharm. 148:139–148 (1997).

New RRC. Liposomes: a practical approach, Oxford University Press, Oxford, 1990.

A. Manosroi, P. Wongtrakul, J. Manosroi, H. Sakai, F. Sugawara, M. Yuasa, and M. Abe. Characterization of vesicles prepared with various non ionic surfactants mixed with cholesterol. Colloids Surf. B Biointerfaces. 30:129–138 (2003).

G.V. Betageri, and D.L. Parsons. Drug encapsulation and release from multilamellar and unilamellar liposomes. Int. J. Pharm. 81:235–241 (1992).